Head and neck atopic dermatitis: still a challenging manifestation in the biologic era

Click to increase image sizeClick to decrease image size

Declaration of interest

A Chiricozzi has served as advisory board member and consultant and has received fees and speaker’s honoraria or has participated in clinical trials for AbbVie, Almirall, Boehringer Ingelheim, Bristol Myers Squibb, Leo Pharma, Lilly, Janssen, Novartis, Pfizer, and Sanofi Genzyme. N Gori served as advisory board member and received honoraria for lectures for AbbVie, Sanofi, and Leo Pharma. E Ippoliti has no conflict of interests to declare. K Peris has served on advisory board, received honoraria for lectures and/or research grants for AbbVie, Almirall, Lilly, Galderma, Leo Pharma, Pierre Fabre, Novartis, Sanofi, Sun Pharma, and Janssen. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.